Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 9/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.64 |
| ▸ | P2RY2 | P41231 | 8/20 | 0.60 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.60 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.55 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.55 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.55 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42134 | 0.88 | SLC28A1 (0.72) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL14199627 | 0.88 | SLC28A1 (0.72) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL14178408 | 0.88 | SLC28A1 (0.72) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL3498224 | 0.88 | SLC28A1 (0.72) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL566229 | 0.88 | SLC28A1 (0.72) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL25513098 | 0.86 | P2RY14 (0.64) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL25513479 | 0.86 | P2RY14 (0.64) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL18269546 | 0.86 | P2RY14 (0.64) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL7611038 | 0.86 | P2RY14 (0.61) | P2RY14P2RY6P2RY2P2RY4SLC28A1 | |
| SCHEMBL6754596 | 0.86 | P2RY14 (0.61) | P2RY14P2RY6P2RY2P2RY4SLC28A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120092014-A | RNA constructs and uses thereof | 生物技术欧洲股份公司 | 2025-06-03 | — | — | CN | claimed |
| CN-117866948-B | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118660973-A | RNA and DNA analysis Using engineered surfaces | 阿丽达生物科学公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118613500-A | Modified mRNA treatment | 沙塔克实验室有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-118176209-A | Treatment involving non-immunogenic RNA and PD-1 axis binding antagonists for antigen vaccination | 生物技术公司 | 2024-06-11 | — | — | CN | claimed |
| CN-118161602-A | RNA for treating autoimmune diseases | 生物技术公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117915945-A | Novel proteins and nucleic acid sequences for COVID-19 vaccines | 东佩制药股份公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117750971-A | Methods of treating or preventing autoimmune diseases | 易姆赛斯股份公司 | 2024-03-22 | — | — | CN | claimed |
| CN-115461509-B | Sulfuric acid composition and use thereof | 六环股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117413065-A | Constructs, methods and uses for the preparation of circular RNAs | 上海环码生物医药有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-111744019-B | Mannose-based mRNA targeted delivery system and application thereof | 深圳瑞吉生物科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| WO-2022000884-A1 | MANNOSE-BASED MRNA TARGETED DELIVERY SYSTEM AND USE THEREOF | 深圳市瑞吉生物科技有限公司 | 2022-01-06 | — | — | WO | claimed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | disclosed |
| CN-122070365-A | Systems and compositions comprising highly active trans-amplified replicase | 百欧恩泰欧洲股份公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122070366-A | Cyclic RNA compositions and methods | 欧纳医疗公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2018075980-A1 | HUMAN CYTOMEGALOVIRUS VACCINE | MODERNATX, INC. (US) | 2018-04-26 | — | — | WO | disclosed |
| WO-2017015630-A2 | MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF | MODERNATX, INC. (US) | 2017-01-26 | — | — | WO | disclosed |
| US-7008782-B2 | Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder | THE UNIVERSITY IOWA RESEARCH FOUNDATION (US) | 2006-03-07 | — | — | US | disclosed |
| WO-2002083725-A1 | NOVEL STRESS PROTEIN WITH CHAPERONE ACTIVITY | RNA INC. (KR) | 2002-10-24 | — | — | WO | disclosed |